rs104886003
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.
|
21430269 |
2011 |
rs121913273
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.
|
21430269 |
2011 |
rs121913279
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.
|
21430269 |
2011 |
rs121913279
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.
|
21430269 |
2011 |
rs104886003
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
High frequency of mutations of the PIK3CA gene in human cancers.
|
15016963 |
2004 |
rs104886003
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
High frequency of mutations of the PIK3CA gene in human cancers.
|
15016963 |
2004 |
rs121913273
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
High frequency of mutations of the PIK3CA gene in human cancers.
|
15016963 |
2004 |
rs121913279
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
High frequency of mutations of the PIK3CA gene in human cancers.
|
15016963 |
2004 |
rs121913279
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
High frequency of mutations of the PIK3CA gene in human cancers.
|
15016963 |
2004 |
rs104886003
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
|
22162589 |
2012 |
rs104886003
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
|
22162589 |
2012 |
rs121913273
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
|
22162589 |
2012 |
rs121913279
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
|
22162589 |
2012 |
rs121913279
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
|
22162589 |
2012 |
rs104886003
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
rs104886003
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
rs121913273
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
rs121913279
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
rs121913279
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
rs104886003
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
PIK3CA mutation status in Japanese lung cancer patients.
|
16930767 |
2006 |
rs104886003
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
PIK3CA mutation status in Japanese lung cancer patients.
|
16930767 |
2006 |
rs121913273
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
PIK3CA mutation status in Japanese lung cancer patients.
|
16930767 |
2006 |
rs121913279
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
PIK3CA mutation status in Japanese lung cancer patients.
|
16930767 |
2006 |
rs121913279
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
PIK3CA mutation status in Japanese lung cancer patients.
|
16930767 |
2006 |
rs104886003
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.
|
20453058 |
2010 |